DFTX · Definium Therapeutics, Inc.
$45.08
+2.28 (+5.33%)
At close · Jul 21
Market Cap
$4.92B
Shares
109.07M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-24 | 2026-06-22 | |
| 8-K | 2026-06-22 | — | |
| 8-K | 2026-06-12 | 2026-06-11 | |
| 8-K | 2026-05-19 | — | |
| 8-K | 2026-05-12 | — | |
| 8-K | 2026-05-07 | — | |
| 10-Q | 2026-05-07 | 2026-03-31 | |
| DEF 14A | 2026-04-27 | 2026-06-11 | |
| 8-K | 2026-04-22 | — | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-01-29 | 2026-01-28 | |
| 8-K | 2026-01-12 | 2026-01-09 | |
| 10-Q | 2025-11-06 | 2025-09-30 | |
| 8-K | 2025-11-06 | — | |
| 8-K | 2025-10-31 | 2025-10-29 | |
| 8-K | 2025-10-29 | — | |
| 8-K | 2025-09-04 | — | |
| 8-K | 2025-07-31 | — | |
| 10-Q | 2025-07-31 | 2025-06-30 | |
| 8-K | 2025-06-16 | — | |
| 8-K | 2025-05-27 | — | |
| 8-K | 2025-05-08 | — | |
| 10-Q | 2025-05-08 | 2025-03-31 | |
| DEF 14A | 2025-04-23 | 2025-06-12 | |
| 8-K | 2025-04-21 | 2025-04-18 | |
| 8-K | 2025-04-15 | — | |
| 8-K | 2025-03-06 | — | |
| 10-K | 2025-03-06 | 2024-12-31 | |
| 8-K | 2025-01-30 | — | |
| 8-K | 2025-01-13 | 2025-01-10 | |
| 8-K | 2024-12-16 | — | |
| 10-Q | 2024-11-07 | 2024-09-30 | |
| 8-K | 2024-11-07 | — | |
| 8-K | 2024-10-17 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-08-12 | 2024-08-09 | |
| 8-K | 2024-06-28 | 2024-05-28 | |
| 8-K | 2024-06-20 | — | |
| 8-K | 2024-06-11 | 2024-06-10 | |
| 8-K | 2024-05-08 | — | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| DEF 14A | 2024-04-26 | 2024-06-10 | |
| 8-K | 2024-04-01 | — | |
| 8-K | 2024-03-11 | 2024-03-07 | |
| 8-K | 2024-03-07 | — | |
| 8-K | 2024-03-07 | — | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-02-28 | — |
Showing 1–50 of 145 filings
Key facts
CIK
1813814
CUSIP
24477V105
13F (30d)
25 filings
25 filers
Visit website
Investor relations